Primary Site >> Stomach Cancer
Gene >> PDCD1
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: [Effect of hepatic arterial infusion chemotherapy for liver metastasis from gastric cancer]. PMID: 12484010 |
Ref: Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer. PMID: 23129549 |
Ref: Molecular biomarkers in gastric cancer. PMID: 26052595 Ref: Upregulation of Immune Checkpoint Molecules, PD-1 and LAG-3, on CD4+ and CD8+ T Cells after Gastric Cancer Surgery. PMID: 26190896 Ref: Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors. PMID: 26617827 |
Ref: Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives. PMID: 27039171 |
Ref: Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer. PMID: 27241062 Ref: Immunotherapy for gastric cancers: emerging role and future perspectives. PMID: 28349740 Ref: The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy. PMID: 28418918 Ref: PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis. PMID: 28796808 Ref: Differentiated tumor immune microenvironment of Epstein-Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy. PMID: 28978018 Ref: [Checkpoint Inhibitors in the Treatment of Upper Gastrointestinal Tract Tumors]. PMID: 29239193 |
Ref: Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression. PMID: 29277762 Ref: Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer. PMID: 29303012 Ref: Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information. PMID: 29360924 Ref: Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients. PMID: 29399387 Ref: Immune Checkpoint Inhibition in Gastro-Oesophageal Cancer. PMID: 29705787 Ref: Tumor-derived exosomes induce PD1(+) macrophage population in human gastric cancer that promotes disease progression. PMID: 29799520 Ref: Mouse-Derived Gastric Organoid and Immune Cell Co-culture for the Study of the Tumor Microenvironment. PMID: 29959712 Ref: PD-L1 Expression and CD8(+) T Cell Infiltration Predict a Favorable Prognosis in Advanced Gastric Cancer. PMID: 30003113 Ref: Co-inhibition of TIGIT, PD1, and Tim3 reverses dysfunction of Wilms tumor protein-1 (WT1)-specific CD8+ T lymphocytes after dendritic cell vaccination in gastric cancer. PMID: 30210924 Ref: Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy. PMID: 30323626 |